Physician

Kimberly M Cheek, MD

According to 2025 Medicare claims, Kimberly Cheek, MD (NPI: 1619995438) practices internal medicine in the Staunton-Stuarts Draft, VA market, with the plurality of this provider's patient population coming from Waynesboro City, VA. This provider's primary affiliated billing organization is AUGUSTA MEDICAL GROUP (NPI: 1245489590; TIN: 262559916) and primary practice location at 22980-1663. Cheek is affiliated with the Augusta Care Partners, LLC (ACO ID: A2266), participating under the MSSP model.

Cheek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 439 traditional Medicare patients, billed 3,243 HCPCS/CPT codes, and received $258,093 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,176 prescription claims across 576 beneficiaries totaling $439,216 in drug costs, led by Ozempic (Semaglutide). DME data shows 24 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $167,954 to $258,093. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $33,918 to $4,681.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	374	2,991	$167,954
2016	397	2,687	$139,979
2017	425	3,025	$153,501
2018	445	2,822	$149,043
2019	483	3,161	$167,982
2020	474	2,447	$134,553
2021	493	2,449	$180,240
2022	483	2,258	$177,333
2023	445	2,203	$173,160
2024	439	3,243	$258,093

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	373	9,154	$406,021
2016	390	9,340	$391,530
2017	423	10,000	$424,627
2018	458	9,684	$425,637
2019	489	9,173	$422,095
2020	528	9,260	$427,790
2021	554	9,317	$428,689
2022	567	8,283	$399,686
2023	563	7,824	$416,342
2024	576	8,176	$439,216

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	80	509	$30,311
2016	49	320	$9,566
2017	43	313	$6,537
2018	40	394	$8,432
2019	38	271	$3,856
2020	34	225	$5,402
2021	22	131	$1,960
2022	18	82	$1,544
2023	13	29	$337
2024	N/R	24	$304

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	318	318	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	429	875	$85
G0008	Administration of influenza virus vaccine	211	219	$25
G0009	Administration of pneumococcal vaccine	207	207	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	355	525	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	66	2,818	$93,336
Eliquis	Apixaban	65	3,431	$66,292
Xarelto	Rivaroxaban	31	2,356	$44,648
Jardiance	Empagliflozin	34	2,100	$39,670
Trulicity	Dulaglutide	25	1,092	$36,682

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	24	$304

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Kimberly M. Cheek, MD?

Tedicare shows public-source Medicare data for Kimberly M. Cheek, MD (NPI 1619995438), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kimberly M. Cheek, MD have ACO affiliation data?

Kimberly M. Cheek, MD is shown with ACO affiliation data for Augusta Care Partners, LLC (MSSP, ACO ID A2266).

What billing organization is linked to Kimberly M. Cheek, MD?

Kimberly M. Cheek, MD is linked to AUGUSTA MEDICAL GROUP (billing NPI 1245489590) in the available physician profile data.

Does Kimberly M. Cheek, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.